Last reviewed · How we verify
NCT06678594: CYCLOPES
Implementation of a Standardized Algorithm for Coronary Calcification With Plaque Modification
trial testing Calcium modification in Myocardial Ischaemia in 500 participants. Currently enrolling.
23 March 2026
Quick facts
| Lead sponsor | Royal College of Surgeons, Ireland |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 500 |
| Start date | 24 September 2024 |
| Primary completion | 23 March 2026 |
| Estimated completion | 23 March 2027 |
| Sites | 1 location across Ireland |
Drugs / interventions tested
- Calcium modification
Conditions studied
- Myocardial Ischaemia — all drugs for Myocardial Ischaemia →
- Severely Calcified Coronary Stenoses — all drugs for Severely Calcified Coronary Stenoses →
- Coronary Calcification — all drugs for Coronary Calcification →
Sponsor
Royal College of Surgeons, Ireland
Who can join
18 and older, any sex, with Myocardial Ischaemia or Severely Calcified Coronary Stenoses. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In this study, the doctors will follow a set of rules that is called an algorithm. An algorithm is a step-by-step approach that doctors use to guide them when making decisions about the best way to treat their patients. Algorithms are useful because they help doctors decide on the best treatment approach based on the patient's individual circumstances and the best medical evidence available. The algorithm that is being used in this study is called a calcium modification algorithm and it will guide doctors when deciding on the best way to modify or break up the calcium in coronary arteries. In this study, we aim to prove that the calcium modification algorithm, described above, safely and effectively guides doctors on the best way to modify calcium in patients' coronary arteries. By doing so, it will help doctors in making decisions about patients' treatment during their procedure. It will also help standardise care for patients, so patients receive the same treatment no matter what hospital they are in or what doctor is treating them.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Workflow-based Framework to Aid with High-Definition Intravascular Ultrasound-Optimised Coronary Stenting: Introducing IVUS 123 Essentials.
Walsh SJ, Cavalcante R, Croce K, Hanratty CG, et al · · 2026 · PMID 41674998 · DOI 10.15420/icr.2025.44 -
A Prospective, Multicenter, Open Label Study Investigating the Implementation of a Standardized Algorithm for Coronary CaLcificatiOn With PlaquE Modification Using UltraSound Guidance to Improve Procedural and Clinical Outcomes (CYCLOPES): Design and Rationale of the CYCLOPES Tri
O'Callaghan D, Durand R, Hanratty CG, Cuisset T, et al · · 2026 · PMID 41408534 · DOI 10.1002/ccd.70424
Verify or expand the search:
- PubMed search for NCT06678594
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Myocardial Ischaemia
Currently open trials in the same condition.
- NCT05824520 — Coronary CT-Derived FFR-Guided Strategy Versus Medical Therapy · NA · recruiting
- NCT04470934 — SeQuent® SCB "All Comers" Post Market Clinical Follow-up (PMCF) · active not recruiting
Other Royal College of Surgeons, Ireland trials
Trials by the same sponsor.
- NCT07443579 — Optimal Mammography View Sequencing in Women With a History of Breast Cancer Undergoing Surveillance Mammography · NA · recruiting
- NCT07426861 — Pre-Operative Nurse-Led Education With Direct Physiotherapy Referral to Reduce Post-Prostatectomy Incontinence · NA · recruiting
- NCT07426835 — The PHARO Trial: The Incidence of Para-conduit Hernia With Closure of Hiatus Versus the Standard Approach in Robotic Oes · NA · recruiting
- NCT07426809 — Margin Optimisation Using Z-axis Assessment With Real-time Tomosynthesis (MOZART Study). · NA · recruiting
- NCT07426848 — OT SMILE: Occupational Therapy Group Intervention for Primary Brain Tumour Patients · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06678594 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Royal College of Surgeons, Ireland
- Last refreshed: 7 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06678594.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing